Variant report

Variant	nsv1040358
Chromosome Location	chr16:12636982-12650247
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:404)
CpG islands
(count:61)
Chromatin interactive
region (count:2)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:404 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr16:12637659-12638979	HepG2	liver:	n/a	n/a
2	ATF2	chr16:12637132-12637535	GM12878	blood:	n/a	n/a
3	ATF2	chr16:12637025-12638683	GM12878	blood:	n/a	n/a
4	ATF2	chr16:12639659-12640191	GM12878	blood:	n/a	n/a
5	ATF2	chr16:12639568-12640202	GM12878	blood:	n/a	n/a
6	ATF2	chr16:12642072-12642853	GM12878	blood:	n/a	n/a
7	ATF2	chr16:12637898-12638419	GM12878	blood:	n/a	n/a
8	ATF2	chr16:12640769-12641712	GM12878	blood:	n/a	n/a
9	ATF2	chr16:12642244-12642881	GM12878	blood:	n/a	n/a
10	ATF2	chr16:12640623-12641853	GM12878	blood:	n/a	n/a
11	BATF	chr16:12641144-12641522	GM12878	blood:	n/a	n/a
12	BATF	chr16:12637743-12638321	GM12878	blood:	n/a	chr16:12637886-12637896
13	BATF	chr16:12640856-12641664	GM12878	blood:	n/a	n/a
14	BATF	chr16:12642156-12642469	GM12878	blood:	n/a	n/a
15	BATF	chr16:12637164-12637545	GM12878	blood:	n/a	n/a
16	BATF	chr16:12642081-12642829	GM12878	blood:	n/a	n/a
17	BATF	chr16:12637100-12637603	GM12878	blood:	n/a	n/a
18	BCL11A	chr16:12641066-12641666	GM12878	blood:	n/a	n/a
19	BCL11A	chr16:12637150-12637604	GM12878	blood:	n/a	n/a
20	BCL11A	chr16:12642225-12642824	GM12878	blood:	n/a	chr16:12642696-12642705
21	BCL11A	chr16:12641124-12641591	GM12878	blood:	n/a	n/a
22	BCL11A	chr16:12637890-12638396	GM12878	blood:	n/a	n/a
23	BCL11A	chr16:12637166-12637556	GM12878	blood:	n/a	n/a
24	BCL3	chr16:12637811-12638327	GM12878	blood:	n/a	n/a
25	BCL3	chr16:12641073-12641684	GM12878	blood:	n/a	n/a
26	BCL3	chr16:12637165-12637549	GM12878	blood:	n/a	n/a
27	BCL3	chr16:12641071-12641581	GM12878	blood:	n/a	n/a
28	BCL3	chr16:12642227-12642860	GM12878	blood:	n/a	chr16:12642696-12642705
29	BCLAF1	chr16:12640683-12641726	GM12878	blood:	n/a	n/a
30	BCLAF1	chr16:12640983-12641815	GM12878	blood:	n/a	n/a
31	BCLAF1	chr16:12637669-12638335	GM12878	blood:	n/a	n/a
32	BCLAF1	chr16:12637158-12638446	GM12878	blood:	n/a	n/a
33	BCLAF1	chr16:12637031-12637643	GM12878	blood:	n/a	n/a
34	BHLHE40	chr16:12637173-12637633	GM12878	blood:	n/a	n/a
35	BHLHE40	chr16:12641106-12641644	GM12878	blood:	n/a	n/a
36	BHLHE40	chr16:12637849-12638304	GM12878	blood:	n/a	n/a
37	BHLHE40	chr16:12639724-12639965	GM12878	blood:	n/a	n/a
38	BHLHE40	chr16:12641903-12642324	GM12878	blood:	n/a	n/a
39	BRCA1	chr16:12641063-12641573	GM12878	blood:	n/a	n/a
40	CEBPB	chr16:12637710-12637987	HepG2	liver:	n/a	n/a
41	CEBPB	chr16:12638768-12638864	IMR90	lung:	n/a	n/a
42	CEBPB	chr16:12637244-12638087	HepG2	liver:	n/a	n/a
43	CEBPB	chr16:12637238-12638067	HepG2	liver:	n/a	n/a
44	CEBPB	chr16:12638349-12639295	HepG2	liver:	n/a	n/a
45	CEBPB	chr16:12636781-12638818	GM12878	blood:	n/a	n/a
46	CEBPB	chr16:12640984-12641671	GM12878	blood:	n/a	n/a
47	CEBPB	chr16:12641269-12641573	GM12878	blood:	n/a	n/a
48	CHD1	chr16:12640752-12641740	GM12878	blood:	n/a	n/a
49	CHD2	chr16:12637267-12637467	GM12878	blood:	n/a	n/a
50	CHD2	chr16:12640942-12641615	GM12878	blood:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr16:12637499-12637549	NHBE	bronchial:	n/a
2	chr16:12637499-12637549	HPAEpiC	pulmonary alveolar:	n/a
3	chr16:12637499-12637549	SK-N-MC	brain:	n/a
4	chr16:12637499-12637549	HMEC	breast:	n/a
5	chr16:12637499-12637549	HRPEpiC	eye:	n/a
6	chr16:12637499-12637549	AG04450	lung:	fetal
7	chr16:12637499-12637549	AG09309	skin:	n/a
8	chr16:12637499-12637549	ovcar-3	ovarian:	n/a
9	chr16:12637499-12637549	RPTEC	kidney:	n/a
10	chr16:12637499-12637549	PFSK-1	brain:	n/a
11	chr16:12637499-12637549	AG04449	skin:	fetal
12	chr16:12637499-12637549	HCF	heart:	n/a
13	chr16:12637499-12637549	Caco-2	colon:	n/a
14	chr16:12637499-12637549	HEEpiC	esophagus:	n/a
15	chr16:12637499-12637549	SK-N-SH	brain:	n/a
16	chr16:12637499-12637549	Jurkat	blood:	n/a
17	chr16:12637499-12637549	GM19239	blood:	n/a
18	chr16:12637499-12637549	HCPEpiC	choroid plexus:	n/a
19	chr16:12637499-12637549	SKMC	muscle:	n/a
20	chr16:12637499-12637549	NH-A	brain:	n/a
21	chr16:12637499-12637549	HRCEpiC	kidney:	n/a
22	chr16:12637499-12637549	HUVEC	blood vessel:	n/a
23	chr16:12637499-12637549	HNPCEpiC	eye:	n/a
24	chr16:12637499-12637549	GM12891	blood:	n/a
25	chr16:12637499-12637549	Hela-S3	cervix:	n/a
26	chr16:12637499-12637549	HCM	heart:	n/a
27	chr16:12637499-12637549	AG10803	skin:	n/a
28	chr16:12637499-12637549	GM06990	blood:	n/a
29	chr16:12637499-12637549	HIPEpiC	eye:	n/a
30	chr16:12637499-12637549	U87	brain:	n/a
31	chr16:12637499-12637549	CMK	blood:	n/a
32	chr16:12637499-12637549	SK-N-SH_RA	brain:	n/a
33	chr16:12637499-12637549	MCF10A-Er-Src	breast:	n/a
34	chr16:12637499-12637549	PrEC	prostate:	n/a
35	chr16:12637499-12637549	H1-hESC	embryonic stem cell:	embryo
36	chr16:12637499-12637549	HCT-116	colon:	n/a
37	chr16:12637499-12637549	BE2_C	brain:	n/a
38	chr16:12637499-12637549	IMR90	lung:	fetal
39	chr16:12637499-12637549	Hepatocyte	liver:	n/a
40	chr16:12637499-12637549	MCF-7	breast:	n/a
41	chr16:12637499-12637549	HRE	kidney:	n/a
42	chr16:12637499-12637549	LNCaP	prostate:	n/a
43	chr16:12637499-12637549	AG09319	gingival:	n/a
44	chr16:12637499-12637549	K562	blood:	n/a
45	chr16:12637499-12637549	SAEC	small airway:	n/a
46	chr16:12637499-12637549	HL-60	blood:	n/a
47	chr16:12637499-12637549	NB4	blood:	n/a
48	chr16:12637499-12637549	ProgFib	skin:	n/a
49	chr16:12637499-12637549	HepG2	liver:	n/a
50	chr16:12637499-12637549	ECC-1	luminal epithelium:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr16:12646912..12648633-chr16:12652435..12654729,2	K562	blood:
2	chr16:12633130..12635327-chr16:12640812..12643626,2	K562	blood:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SHISA9-4	chr16:12639339-12639458	ENSG00000260601.1
2	lnc-CPPED1-3	chr16:12650210-12650396	ENSG00000259876.1
3	lnc-SHISA9-4	chr16:12640142-12640541	ENSG00000260601.1

No data

Variant related genes	Relation type
ENSG00000260601	TF binding region
ENSG00000260601	CpG island

Extended variants
information (count: 2175 )
Associated
traits (count: 69 )

Variant overlapped rSNPs/rCNVs (count:2175 , 50 per page) page: 1 2 3 4 5 6 7 ... 44

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1615250	chr16:12636982-12636983	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs536084383	chr16:12636992-12636993	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs576771817	chr16:12637001-12637002	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs149658159	chr16:12637004-12637005	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs145473797	chr16:12637008-12637009	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs148838977	chr16:12637009-12637010	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs180794715	chr16:12637036-12637037	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs200295301	chr16:12637040-12637041	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs1616112	chr16:12637079-12637080	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs143504568	chr16:12637083-12637084	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs530758448	chr16:12637084-12637085	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs542459363	chr16:12637099-12637100	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs185207951	chr16:12637100-12637101	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs572216077	chr16:12637102-12637103	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs540999940	chr16:12637122-12637123	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs564339374	chr16:12637127-12637128	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs11640817	chr16:12637128-12637129	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs369987679	chr16:12637143-12637144	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs78507434	chr16:12637147-12637148	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs570385051	chr16:12637150-12637151	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs28501600	chr16:12637162-12637163	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs147599947	chr16:12637167-12637168	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs539009561	chr16:12637168-12637169	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs549610898	chr16:12637181-12637182	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs565735163	chr16:12637192-12637193	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs547059064	chr16:12637200-12637201	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs551321232	chr16:12637202-12637203	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs571138480	chr16:12637212-12637213	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs537076059	chr16:12637213-12637214	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs556972199	chr16:12637220-12637221	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs567169554	chr16:12637226-12637227	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs567591147	chr16:12637228-12637229	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs189289376	chr16:12637232-12637233	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs572175126	chr16:12637236-12637237	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs182032914	chr16:12637242-12637243	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs557400315	chr16:12637245-12637246	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs577956090	chr16:12637261-12637262	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs116482694	chr16:12637280-12637281	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs546308652	chr16:12637282-12637283	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs563792138	chr16:12637288-12637289	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs147515450	chr16:12637296-12637297	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs529618726	chr16:12637306-12637307	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs115778066	chr16:12637311-12637312	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs113895692	chr16:12637328-12637329	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs560001793	chr16:12637333-12637334	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs728583	chr16:12637335-12637336	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs141749857	chr16:12637344-12637345	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs569402076	chr16:12637345-12637346	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs571366645	chr16:12637348-12637349	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs147096708	chr16:12637353-12637354	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:69)

Disease	PMID	Source
Cancer	21183584	CNVD
Follicular lymphoma	20505157	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	16573809	CNVD
Breast cancer	17603634	CNVD
Hodgkin''s lymphoma	20651079	CNVD
Metanephric adenoma	20802469	CNVD
Melanoma	18172304	CNVD
Breast cancer	16608533	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Lung adenocarcinoma	17086460	CNVD
Lung cancer	17086460	CNVD
Autism	22566537	CNVD
Intellectual disability	22566537	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Lung cancer	18438408	CNVD
Ductal carcinoma	22052326	CNVD
Breast cancer	21509527	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22102821	CNVD
Autism	22495311	CNVD
idiopathic generalized epilepsy	19843651	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Intellectual disability	22102821	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Prostate cancer	18632612	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	20553308	CNVD
Autism	19786961	CNVD
Mental retardation	19786961	CNVD
Schizophrenia	19786961	CNVD
Mental retardation	19951919	CNVD
Autism	18791038	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Malignant germ cell tumour	17285132	CNVD
Autism	17480035	CNVD
Schizophrenia	19955444	CNVD
Breast cancer	21858162	CNVD
Myelofibrosis	22110671	CNVD
Mental retardation	17847001	CNVD
Schizophrenia	23813976	CNVD

Chromatin state (count:305 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:12613000-12670800	Weak transcription	Pancreas	Pancrea
2	chr16:12625800-12643400	Weak transcription	Gastric	stomach
3	chr16:12627000-12642200	Weak transcription	Right Ventricle	heart
4	chr16:12630400-12637000	Weak transcription	Primary T cells from cord blood	blood
5	chr16:12630400-12638800	Weak transcription	Fetal Thymus	thymus
6	chr16:12630600-12637200	Weak transcription	Spleen	Spleen
7	chr16:12632800-12637000	Weak transcription	Skeletal Muscle Male	skeletal muscle
8	chr16:12632800-12638600	Weak transcription	Lung	lung
9	chr16:12632800-12640200	Weak transcription	Primary T helper cells PMA-I stimulated	--
10	chr16:12632800-12641000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
11	chr16:12632800-12646600	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
12	chr16:12632800-12663800	Weak transcription	Aorta	Aorta
13	chr16:12633000-12638400	Weak transcription	Brain Angular Gyrus	brain
14	chr16:12633000-12638400	Weak transcription	Brain Hippocampus Middle	brain
15	chr16:12633000-12646600	Weak transcription	Brain Cingulate Gyrus	brain
16	chr16:12633200-12638400	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
17	chr16:12633200-12640600	Weak transcription	Stomach Mucosa	stomach
18	chr16:12633200-12640800	Weak transcription	Duodenum Mucosa	Duodenum
19	chr16:12633400-12654400	Weak transcription	Stomach Smooth Muscle	stomach
20	chr16:12633600-12637400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
21	chr16:12633600-12638400	Weak transcription	Brain Substantia Nigra	brain
22	chr16:12633600-12639000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
23	chr16:12633600-12640000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
24	chr16:12633800-12637200	Weak transcription	Muscle Satellite Cultured Cells	--
25	chr16:12633800-12637800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
26	chr16:12633800-12640000	Weak transcription	NHEK	skin
27	chr16:12634000-12637600	Weak transcription	Monocytes-CD14+_RO01746	blood
28	chr16:12634200-12638600	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
29	chr16:12634200-12640600	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
30	chr16:12634400-12637600	Weak transcription	Primary monocytes fromperipheralblood	blood
31	chr16:12634400-12638000	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
32	chr16:12635000-12644200	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
33	chr16:12635200-12638600	Weak transcription	Primary T cells fromperipheralblood	blood
34	chr16:12635400-12637200	Enhancers	HepG2	liver
35	chr16:12635400-12639000	Weak transcription	Sigmoid Colon	Sigmoid Colon
36	chr16:12635400-12640600	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
37	chr16:12635600-12639200	Weak transcription	Esophagus	oesophagus
38	chr16:12635600-12641000	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
39	chr16:12635800-12637800	Weak transcription	Brain Inferior Temporal Lobe	brain
40	chr16:12636000-12637000	Enhancers	Primary B cells from peripheral blood	blood
41	chr16:12636000-12637000	Weak transcription	HSMM	muscle
42	chr16:12636000-12642600	Flanking Active TSS	GM12878-XiMat	blood
43	chr16:12636400-12637600	Weak transcription	Primary B cells from cord blood	blood
44	chr16:12636400-12640600	Weak transcription	Primary neutrophils fromperipheralblood	blood
45	chr16:12636800-12637400	Enhancers	HSMMtube	muscle
46	chr16:12637000-12637400	Enhancers	HSMM	muscle
47	chr16:12637000-12637600	Enhancers	Skeletal Muscle Male	skeletal muscle
48	chr16:12637000-12638600	Genic enhancers	Primary B cells from peripheral blood	blood
49	chr16:12637000-12638600	Strong transcription	Primary T cells from cord blood	blood
50	chr16:12637000-12638600	Enhancers	Fetal Muscle Leg	muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links